يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Translational research Tissue engineering and pathology [ONCOL 3]"', وقت الاستعلام: 1.26s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Visco, C, Tzankov, A, Xu Monette, Zy, Miranda, Rn, Tai, Yc, Li, Y, Liu, Wm, D'Amore, E, Montes Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Wang, Hy, Dunphy, Ch, O' Neill, S, Hsi, Ed, Zhao, Xf, Choi, Ww, Zhao, X, van Krieken, Jh, Huang, Q, Ai, W, Ponzoni, Maurilio, Ferreri, Aj, Kahl, B, Winter, Jn, Go, R, Dirnhofer, S, Piris, Ma, Møller, Mb, Wu, L, Medeiros, Lj, Young, K. H.

    المصدر: Visco, C, Tzankov, A, Xu-Monette, Z Y, Miranda, R N, Tai, Y C, Li, Y, Liu, W M, d'Amore, E S G, Li, Y, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Wang, H Y, Dunphy, C H, His, E D, Zhao, X F, Choi, W W L, Zhao, X, Han van Krieken, J, Huang, Q, Ai, W, O'Neill, S, Ponzoni, M, Ferreri, A J M, Kahl, B S, Winter, J N, Go, R S, Dirnhofer, S, Piris, M A, Møller, M B, Wu, L, Medeiros, L J & Young, K H 2013, ' Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status : A report from an international DLBCL rituximab-CHOP consortium program study ', Haematologica, vol. 98, no. 2, pp. 255-263 . https://doi.org/10.3324/haematol.2012.066209Test
    Visco, C, Tzankov, A, Xu-Monette, Z Y, Miranda, R N, Tai, Y C, Li, Y, Liu, W-M, d'Amore, E S G, Li, Y, Montes-Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Wang, H-Y, Dunphy, C H, O' Neill, S, Hsi, E D, Zhao, X F, Choi, W W L, Zhao, X, van Krieken, J H, Huang, Q, Ai, W, Ponzoni, M A, Ferreri, A J M, Kahl, B S, Winter, J N, Go, R S, Dirnhofer, S, Piris, M A, Møller, M B, Wu, L, Medeiros, L J & Young, K H 2012, ' Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status : a report from an International DLBCL rituximab-CHOP Consortium Program Study ', Haematologica . https://doi.org/10.3324/haematol.2012.066209Test
    Haematologica, 98, 255-63
    Haematologica, 98, 2, pp. 255-63

    وصف الملف: application/pdf

  3. 3

    المساهمون: Xu Monette, Zy, Møller, Mb, Tzankov, A, Montes Moreno, S, Hu, W, Manyam, Gc, Kristensen, L, Fan, L, Visco, C, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Bhagat, G, Richards, Kl, Hsi, Ed, Choi, Ww, van Krieken, Jh, Huang, Q, Huh, J, Ai, W, Ponzoni, Maurilio, Ferreri, Aj, Wu, L, Zhao, X, Bueso Ramos, Ce, Wang, Sa, Go, R, Li, Y, Winter, Jn, Piris, Ma, Medeiros, Lj, Young, Kh

    المصدر: Xu-Monette, Z Y, Møller, M, Tzankov, A, Montes-Moreno, S, Hu, W, Manyam, G C, Kristensen, L, Fan, L, Visco, C, Dybkær, K, Chiu, A, Tam, W, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huang, Q, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Winter, J N, Wu, L, Zhao, X, Go, R S, Wang, S A, Bueso-Ramos, C E, Li, Y, Piris, M A, Medeiros, L J & Young, K H 2013, ' MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy : a report from the international DLBCL rituximab-CHOP consortium program ', Blood, vol. 122, no. 15, pp. 2630-2640 . https://doi.org/10.1182/blood-2012-12-473702Test
    Blood, 122, 15, pp. 2630-40
    Xu-Monette, Z Y, Møller, M B, Tzankov, A, Montes-Moreno, S, Hu, W, Manyam, G C, Kristensen, L, Fan, L, Visco, C, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huang, Q, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Wu, L, Zhao, X, Bueso-Ramos, C E, Wang, S A, Go, R S, Li, Y, Winter, J N, Piris, M A, Medeiros, L J & Young, K H 2013, ' MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy : a report from the International DLBCL Rituximab-CHOP Consortium Program ', Blood, vol. 122, no. 15, pp. 2630-40 . https://doi.org/10.1182/blood-2012-12-473702Test
    Blood, 122, 2630-40
    Scopus-Elsevier

    وصف الملف: application/pdf

  4. 4
  5. 5

    المساهمون: University of Zurich, Oschlies, Ilske

    المصدر: Haematologica, 98, 1, pp. 50-6
    Haematologica, 98, 50-6

    وصف الملف: application/pdf; Oschlies_Haem_2012.pdf - application/pdf

  6. 6

    المساهمون: Hu, S, Xu Monette, Zy, Tzankov, A, Green, T, Wu, L, Balasubramanyam, A, Liu, Wm, Visco, C, Li, Y, Miranda, Rn, Montes Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, Kl, Hsi, Ed, Choi, Ww, Zhao, X, van Krieken, Jh, Huang, Q, Huh, J, Ai, W, Ponzoni, Maurilio, Ferreri, Aj, Zhou, F, Slack, Gw, Gascoyne, Rd, Tu, M, Variakojis, D, Chen, W, Go, R, Piris, Ma, Møller, Mb, Medeiros, Lj, Young, Kh

    المصدر: Hu, S, Xu-Monette, Z Y, Tzankov, A, Green, T, Wu, L, Balasubramanyam, A, Liu, W, Visco, C, Li, Y, Miranda, R N, Montes-Moreno, S, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, Zhao, X, van Krieken, J H, Huang, Q, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Zhou, F, Slack, G W, Gascoyne, R D, Tu, M, Variakojis, D, Chen, W, Go, R S, Piris, M A, Møller, M B, Medeiros, L J & Young, K H 2013, ' MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures : a report from The International DLBCL Rituximab-CHOP Consortium Program ', Blood, vol. 121, no. 20, pp. 4021-31; quiz 4250 . https://doi.org/10.1182/blood-2012-10-460063Test
    Blood, 121, 4021-31
    Hu, S, Xu-Monette, Z Y, Tzankov, A, Green, T, Wu, L, Balasubramanyam, A, Liu, W, Visco, C, Li, Y, Miranda, R N, Montes-Moreno, S, Dybkær, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, Zhao, X, van Krieken, J H, Huang, Q, Huh, J, Ai, W, Ponzoni, M, Ferreri, A J M, Zhou, F, Slack, G W, Gascoyne, R D, Tu, M, Variakojis, D, Chen, W, Go, R S, Piris, M A, Møller, M, Medeiros, L J & Young, K H 2013, ' MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures : a report from The International DLBCL Rituximab-CHOP Consortium Program ', Blood, vol. 121, no. 20, pp. 4021-31; quiz 4250 . https://doi.org/10.1182/blood-2012-10-460063Test
    Blood, 121, 20, pp. 4021-31

    وصف الملف: application/pdf

  7. 7

    المساهمون: Frei, E, Visco, C, Xu Monette, Zy, Dirnhofer, S, Dybkær, K, Orazi, A, Bhagat, G, Hsi, Ed, van Krieken, Jh, Ponzoni, Maurilio, Go, R, Piris, Ma, Møller, Mb, Young, Kh, Tzankov, A.

    المصدر: Frei, E, Visco, C, Xu-Monette, Z Y, Dirnhofer, S, Dybkær, K, Orazi, A, Bhagat, G, Hsi, E D, van Krieken, J H, Ponzoni, M, Go, R S, Piris, M A, Møller, M B, Young, K H & Tzankov, A 2013, ' Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma ', Journal of Clinical Pathology, vol. 66, no. 11, pp. 956-961 . https://doi.org/10.1136/jclinpath-2013-201619Test
    Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 66, 11, pp. 956-61
    Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 66, 956-61

  8. 8
  9. 9
  10. 10

    المساهمون: Li, Y, Gordon, Mw, Xu Monette, Zy, Visco, C, Tzankov, A, Zou, D, Qiu, L, Montes Moreno, S, Dybkaer, K, Orazi, A, Zu, Y, Bhagat, G, Richards, Kl, Hsi, Ed, Choi, Ww, van Krieken, Jh, Huang, Q, Ai, W, Ponzoni, Maurilio, Ferreri, Aj, Winter, Jn, Go, R, Piris, Ma, Møller, Mb, Wu, L, Wang, M, Ramos, K, Medeiros, Lj, Young, K. H.

    المصدر: Blood, 121, 4529-40
    Li, Y, Gordon, M W, Xu-Monette, Z Y, Visco, C, Tzankov, A, Zou, D, Qiu, L, Montes-Moreno, S, Dybkaer, K, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huang, Q, Ai, W, Ponzoni, M, Ferreri, A J M, Winter, J N, Go, R S, Piris, M A, Møller, M B, Wu, L, Wang, M, Ramos, K S, Medeiros, L J & Young, K H 2013, ' Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP : a report from the International DLBCL Rituximab-CHOP Consortium Program ', Blood, vol. 121, no. 22, pp. 4529-40 . https://doi.org/10.1182/blood-2012-12-471722Test
    Li, Y, Gordon, M W, Xu-Monette, Z Y, Visco, C, Tzankov, A, Zou, D, Qiu, L, Montes-Moreno, S, Dybkær, K, Orazi, A, Zu, Y, Bhagat, G, Richards, K L, Hsi, E D, Choi, W W L, van Krieken, J H, Huang, Q, Ai, W, Ponzoni, M, Ferreri, A J M, Winter, J N, Go, R S, Piris, M A, Møller, M B, Wu, L, Wang, M, Ramos, K S, Medeiros, L J & Young, K H 2013, ' Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP : a report from the International DLBCL Rituximab-CHOP Consortium Program ', Blood, vol. 121, no. 22, pp. 4529-40 . https://doi.org/10.1182/blood-2012-12-471722Test
    Blood, 121, 22, pp. 4529-40

    وصف الملف: application/pdf